Marksman Partners, L.P. v. Chantal Pharmaceutical Corp.
Opinion
Opinion
Rea, J.
ORDER
1) DENYING CHANTAL PHARMACEUTICAL CORP. AND CHANTAL BURNISON’S MOTION FOR SUMMARY JUDGMENT, 2) DENYING STANSON MARKETING, INC. AND FRED REINSTEIN’S MOTION FOR SUMMARY. JUDGMENT, and 3) GRANTING COOPERS & LYBRAND L.L.P.’S MOTION FOR SUMMARY JUDGMENT
On February 22, 1999, the Court heard oral argument regarding three separate motions for summary judgment brought by (1) Chantal Pharmaceutical Corporation (“Chantal”) and Chantal Burnison (“Burni-son”), (2) Stanson Marketing, Inc. (“Stan-son”) and Fred Reinstein (“Reinstein”), and (3) Coopers & Lybrand L.L.P. (“C & L”). After oral argument, the Court took each of the motions under submission for further consideration.
The Court now rules in accordance with its tentative ruling that was issued to the parties on February 22, 1999.. Thus, the Court hereby denies Chantal and Burni-son’s, and Stanson and Reinstein’s Motions for Summary Judgment as there are genuine issues of material fact relating to the claims against these parties. In addition, the Court hereby grants C & L’s Motion for Summary Judgment as there are no genuine issues of material fact relating to the claim against C & L.